The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients
Allergic rhinitis (AR) is a common problem and we sought to examine the burden of disease and its management in Canada from the perspectives of patients and physicians.
Two parallel, Canadawide structured telephone interviews surveyed 1,001 AR patients and 160 physicians in July 2006.
44% of patients had experienced nasal symptoms unrelated to a cold and 20% had a physician diagnosis of AR. At screening 27% reported asthma, 15% chronic or recurrent sinusitis and 5% nasal polyps. With attacks nasal congestion and runny nose were the most bothersome symptoms. Other problems experienced were fatigue (46%), poor concentration (32%), and reduced productivity (23%). Most (77%) had not seen a physician in the past year. Physicians estimated they prescribed intranasal cortico steroids (INCS) to most AR patients (77%) consistent with guidelines but only 19% of patients had used one in the last month. Only 48% of patients were very satisfied with their current INCS. 41% of AR patients reported discontinuing their INCS with the most common reason being a perceived lack of long-lasting symptom relief (44%). 52% of patients felt that their current INCS lost effectiveness over 24 h. The most common INCS side effects included dripping down the throat, bad taste, and dryness. Most AR patients reported lifestyle limitations despite treatment (66%). 61% of patients felt that their symptoms were only somewhat controlled or poorly/not controlled during their worst month in the past year.
AR symptoms are common and many patients experience inadequate control. Physicians report they commonly prescribe intranasal corticosteroids, but patient’s perceived loss of efficacy and side effects lead to their discontinuation. Persistent relief of allergic rhinitis symptoms remains a major unmet need. Better treatments and education are required.
- Bousquet, J, Khaltaev, N, Cruz, AA, Denburg, J, Fokkens, WJ, Togias, A (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63: pp. 8-160 CrossRef
- Pawankar, R (2007) Inflammatory mechanisms in allergic rhinitis. Curr Opin Allergy Clin Immunol 7: pp. 1-4 CrossRef
- Allergies and Asthma brochure.
- Beggs, PJ (2004) Impacts of climate change on aeroallergens: past and future. Clin Exp Allergy 34: pp. 1507-1513 CrossRef
- Rogers, CA, Wayne, PM, Macklin, EA, Muilenberg, ML, Wagner, CJ, Epstein, PR (2006) Interaction of the onset of spring and elevated atmospheric CO2 on ragweed (Ambrosia artemisiifolia L.) pollen production. Environ Health Perspect 114: pp. 865-869 CrossRef
- Bahls, C (2007) In the clinic. Allergic rhinitis. Ann Intern Med 146: pp. 1-13
- Price, D, Bond, C, Bouchard, J, Costa, R, Keenan, J, Levy, ML (2006) International Primary Care Respiratory Group (IPCRG) Guidelines: management of allergic rhinitis. Prim Care Respir J 15: pp. 58-70 CrossRef
- Dykewicz, MS, Fineman, S (1998) Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. Ann Allergy Asthma Immunol 81: pp. 463-468 CrossRef
- Weiner, JM, Abramson, MJ, Puy, RM (1998) Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 317: pp. 1624-1629 CrossRef
- Agency for Healthcare Research and Quality [homepage on the internet]: Management of allergic and nonallergic rhinitis. Available from: http://www.aafa.org/display.cfm?id=7&sub=92&cont=529
- Asthma and Allergy Foundation of America [homepage on the internet]: New survey reveals patients may want more from their allergy medication. Available from: http://www.aafa.org/display.cfm?id=7&sub=92&cont=529
- Marple, BF, Fornadley, JA, Patel, AA, Fineman, SM, Fromer, L, Krouse, JH (2007) Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg 136: pp. S107-S124 CrossRef
- Nathan, RA (2007) The burden of allergic rhinitis. Allergy Asthma Proc 28: pp. 3-9 CrossRef
- Data on file. HealthSTAR Communications. Allergies in America: A Landmark Survey of Nasal Allergy Sufferers. Executive Summary. Altana Pharma US, Inc, Florham Park; 2006.
- Bousquet, J, Van, CP, Khaltaev, N (2001) Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108: pp. S147-S334 CrossRef
- Leith, E, Bowen, T, Butchey, J, Fischer, D, Kim, H, Moote, B (2006) Consensus guidelines on practical issues of immunotherapy–Canadian Society of Allergy and Clinical Immunology. Allergy Asthma Clin Immunol 2: pp. 47-61
- Keith, PK, Luciuk, G (2007) Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trial. Clin Ther 29: pp. 419-426 CrossRef
- Kremer, B, Den Hartog, HM, Jolles, J (2002) Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being. Clin Exp Allergy 32: pp. 1310-1315 CrossRef
- Leger, D, nnesi-Maesano, I, Carat, F, Rugina, M, Chanal, I, Pribil, C (2006) Allergic rhinitis and its consequences on quality of sleep: An unexplored area. Arch Intern Med 166: pp. 1744-1748 CrossRef
- Szeinbach, SL, Seoane-Vazquez, EC, Beyer, A, Williams, PB (2007) The impact of allergic rhinitis on work productivity. Prim Care Respir J 16: pp. 98-105 CrossRef
- Meltzer, EO (2001) Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 108: pp. S45-S53 CrossRef
- Meltzer, EO, Kunjibettu, S, Hall, N, Wingertzahn, MA, Murcia, C, Berger, W (2007) Efficacy and safety of ciclesonide, 200 microg once daily, for the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol 98: pp. 175-181 CrossRef
- Bachert, C, Vignola, AM, Gevaert, P, Leynaert, B, van, CP, Bousquet, J (2004) Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin North Am 24: pp. 19-43 CrossRef
- Canova, CR, Downs, SH, Knoblauch, A, Andersson, M, Tamm, M, Leuppi, JD (2004) Increased prevalence of perennial allergic rhinitis in patients with obstructive sleep apnea. Respiration 71: pp. 138-143 CrossRef
- Corren, J (2007) The connection between allergic rhinitis and bronchial asthma. Curr Opin Pulm Med 13: pp. 13-18 CrossRef
- Keith, PK, Conway, M, Evans, S, Wong, DA, Jordana, G, Pengelly, D (1994) Nasal polyps: effects of seasonal allergen exposure. J Allergy Clin Immunol 93: pp. 567-574 CrossRef
- Bousquet, J, Lund, VJ, van, CP, Bremard-Oury, C, Mounedji, N, Stevens, MT (2003) Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy 58: pp. 733-741 CrossRef
- Juniper, EF, Guyatt, GH (1991) Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 21: pp. 77-83 CrossRef
- Revicki, DA, Leidy, NK, Brennan-Diemer, F, Thompson, C, Togias, A (1998) Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res 7: pp. 693-702 CrossRef
- Santilli, J, Nathan, R, Glassheim, J, Rockwell, W, Gold, K (2001) Validation of the rhinitis outcomes questionnaire (ROQ). Ann Allergy Asthma Immunol 86: pp. 222-225 CrossRef
- The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Allergy, Asthma & Clinical Immunology
- Online Date
- June 2012
- Online ISSN
- BioMed Central
- Additional Links
- Rhinitis, Allergic
- Anti-allergic agents
- Administration, Intranasal
- Quality of life
- Author Affiliations
- 1. McMaster University, Hamilton, ON, Canada
- 2. Hôtel-Dieu de Montréal, Montreal, QC, Canada
- 3. Nycomed: A Takeda Company, Oakville, ON, Canada
- 4. Pacific Lung Health Centre, St. Paul’s Hospital, Vancouver, BC, Canada